Literature DB >> 1911009

Disposition of mepivacaine and bupivacaine enantiomers in sheep.

L E Mather1.   

Abstract

Mepivacaine and bupivacaine are used clinically as racemic mixtures of enantiomers. In these studies the enantiomers of each agent were administered separately to sheep by i.v. bolus injection on separate occasions. Enantioselective disposition was deemed if the R:S ratio of the relevant pharmacokinetic parameter differed significantly from unity. Both enantiomers of both agents were cleared principally by the liver; urinary excretion of unmetabolized agents accounted for less than 2% of the doses. For R(-)-and S(+)-mepivacaine, respective mean (SEM) values of parameters were: total body clearance 1.20 (0.29) litre min-1 and 0.97 (0.20) litre min-1 (ns); total volume of distribution 144 (39) litre and 80 (21) litre (P less than 0.05); slow half-life 120 (40) min and 84 (22) min (ns); mean hepatic extraction ratio 0.50 (0.14) and 0.52 (0.09) (ns); mean hepatic clearance 0.75 (0.23) litre min-1 and 0.75 (0.18) litre min-1 (ns). For R(+)- and S(-)-bupivacaine, respective values were: total body clearance 0.77 (0.33) litre min-1 and 0.53 (0.26) litre min-1 (P less than 0.05); total volume of distribution 40 (10) litre and 43 (10) litre (ns); slow half-life 57 (10) min and 104 (21) min (P less than 0.05); mean hepatic extraction ratio 0.46 (0.15) and 0.29 (0.13) (P less than 0.05); mean hepatic clearance 0.85 (0.31) litre min-1 and 0.54 (0.26) litre min-1 (P less than 0.05). Thus there was enantioselective distribution of mepivacaine and enantioselective clearance of bupivacaine, but the magnitude of the effect was relatively small.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911009     DOI: 10.1093/bja/67.3.239

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  8 in total

1.  Direct cardiac effects of intracoronary bupivacaine, levobupivacaine and ropivacaine in the sheep.

Authors:  D H Chang; L A Ladd; S Copeland; M A Iglesias; J L Plummer; L E Mather
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

Review 2.  Cardiotoxicity with modern local anaesthetics: is there a safer choice?

Authors:  L E Mather; D H Chang
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Pharmacokinetics of bupivacaine enantiomers in sheep: influence of dosage regimen and study design.

Authors:  L E Mather; A J Rutten; J L Plummer
Journal:  J Pharmacokinet Biopharm       Date:  1994-12

Review 4.  Recent advances in the pharmacokinetics of local anaesthetics. Long-acting amide enantiomers and continuous infusions.

Authors:  J M Thomas; S A Schug
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

5.  Pharmacokinetics of the enantiomers of bupivacaine following intravenous administration of the racemate.

Authors:  A G Burm; A D van der Meer; J W van Kleef; P W Zeijlmans; K Groen
Journal:  Br J Clin Pharmacol       Date:  1994-08       Impact factor: 4.335

6.  Safety Evaluation of EXPAREL (DepoFoam Bupivacaine) Administered by Repeated Subcutaneous Injection in Rabbits and Dogs: Species Comparison.

Authors:  Brigitte M Richard; Douglas E Rickert; Paul E Newton; Laura R Ott; Dean Haan; Abram N Brubaker; Phaedra I Cole; Paul E Ross; Marlon C Rebelatto; Keith G Nelson
Journal:  J Drug Deliv       Date:  2011-10-05

7.  Efficacy and safety of bupivacaine versus lidocaine in dental treatments: a meta-analysis of randomised controlled trials.

Authors:  Naichuan Su; Hang Wang; Shu Zhang; Shuang Liao; Shuying Yang; Yi Huang
Journal:  Int Dent J       Date:  2013-10-11       Impact factor: 2.607

Review 8.  Chiral Aspects of Local Anesthetics.

Authors:  Ružena Čižmáriková; Jozef Čižmárik; Jindra Valentová; Ladislav Habala; Mário Markuliak
Journal:  Molecules       Date:  2020-06-12       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.